Submit Content
Get the latest delivered to your inbox
Privacy Policy

Now Reading

HBCU Students Weigh in on Biogen Experience

HBCU Students Weigh in on Biogen Experience

Published 02-16-22

Submitted by Biogen

Pioneering neuroscience and driving innovation comes from a truly diverse workforce. Our partnership with HBCUs and student internship program helps drive our efforts to ensure our future leaders come from all backgrounds.

Watch this video to hear more from our past interns.

Learn more about Diversity, Equity & Inclusion at Biogen

Biogen Logo



At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, commercializes biosimilars of advanced biologics and is focused on advancing research programs in multiple sclerosis and neuroimmunology, Alzheimer’s disease and dementia, neuromuscular disorders, movement disorders, ophthalmology, immunology, neurocognitive disorders, acute neurology and pain. We routinely post information that may be important to investors on our website at To learn more, please visit and follow us on social media - Twitter, LinkedIn, Facebook, YouTube.

More from Biogen

Join today and get the latest delivered to your inbox